The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM
Open accessAbstract
A wide variety of human adult and fetal tissues were studied by immune-diffusion techniques in agar gel to determine whether they contained the tumor-specific antigen(s) previously found in coionic cancers. In the adult tissues it was demonstrated that identical antigens were present in all tested specimens of malignant tumors of the entodermally derived epithelium of the gastrointestinal tract and pancreas, but were absent from all other tested adult tissues. The common antigenic constituents, therefore, represent system-specific cancer antigens of the human digestive system. System-specific cancer antigens have not previously been demonstrated in humans. Experiments with fetal tissues demonstrated that identical antigens were also present in fetal gut, liver, and pancreas between 2 and 6 months of gestation. These components were named "carcinoembryonic" antigens of the human digestive system. On the basis of the present findings and the recent work regarding control of the expression of genetic potentialities in various types of cells, it was concluded that the carcinoembryonic antigens represent cellular constituents which are repressed during the course of differentiation of the normal digestive system epithelium and reappear in the corresponding malignant cells by a process of derepressive-dedifferentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic regulatory mechanisms in the synthesis of proteins.
Jacob, F., & Monod, J. (1961) · Journal of Molecular Biology · doi:10.1016/s0022-2836(61)80072-7 · Cited by 5,300
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.121.3.439 · Cited by 2,310
Self-citationGeneral Conclusions: Teleonomic Mechanisms in Cellular Metabolism, Growth, and Differentiation
Monod, J., & Jacob, F. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.048 · Cited by 1,072
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
Kleinsmith, L. J., & Pierce, G. B. (1964) · PubMed · Cited by 987
DELETION OF THE CHOLESTEROL-NEGATIVE FEEDBACK SYSTEM IN LIVER TUMORS.
Siperstein, M. D., & Fagan, V. M. (1964) · PubMed · Cited by 168
Cited by
Hammarström, S. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0119 · Cited by 1,300
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Alpha-Fetoprotein in Ontogenesis and its Association with Malignant Tumors
(1971) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60523-0 · Cited by 877
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Goldenberg, D. M., DeLand, F., Kim, E., Bennett, S., Primus, F. J., van Nagell, J. R., Estes, N., DeSimone, P., & Rayburn, P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806222982503 · Cited by 756
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
THE RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN OF THE HUMAN DIGESTIVE SYSTEM
Thomson, D. M. P., Krupey, J., Freedman, S. O., & Gold, P. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.1.161 · Cited by 698
Self-citationOccurrence of malignancy in immunodeficiency diseases: A literature review
Gatti, R. A., & Good, R. A. (1971) · Cancer · doi:10.1002/1097-0142(197107)28:1<89::aid-cncr2820280117>3.0.co;2-q · Cited by 632
Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives
Thompson, J. A., Grunert, F., & Zimmermann, W. (1991) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860050510 · Cited by 608
Enzyme-linked Immunosorbent Assay, ELISA
ENGVALL, E., & PERLMANN, P. (1972) · Protides of the Biological Fluids · doi:10.1016/b978-0-08-016876-0.50102-x · Cited by 585
Beauchemin, N., & Arabzadeh, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9444-6 · Cited by 538
New Paths in Human Cancer Serology
Old, L. J., & Chen, Y.-T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1163 · Cited by 446
Sloane, J. P., & Ormerod, M. G. (1981) · Cancer · doi:10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8 · Cited by 402
Compton, C. C., Byrd, D. R., Garcia-Aguilar, J., Kurtzman, S. H., Olawaiye, A., & Washington, M. K. (2012) · AJCC Cancer Staging Atlas · doi:10.1007/978-1-4614-2080-4_14 · Cited by 395
Cellular and Humoral immunity to Different Types of Human Neoplasms
HELLSTRÖM, I., HELLSTRÖM, K. E., PIERCE, G. E., & YANG, J. P. S. (1968) · Nature · doi:10.1038/2201352a0 · Cited by 393
Mach, J.-P., Carrel, S., Forni, M., Ritschard, J., Donath, A., & Alberto, P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007033030102 · Cited by 393
CEACAMs: their role in physiology and pathophysiology
Kuespert, K., Pils, S., & Hauck, C. R. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.008 · Cited by 384
Mach, J.-P., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Lumbroso, J.-D., Schreyer, M., Girardet, C., Accolla, R. S., & Carrel, S. (1981) · Immunology Today · doi:10.1016/0167-5699(81)90011-6 · Cited by 376
The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers
Anderson, K. S., & LaBaer, J. (2005) · Journal of Proteome Research · doi:10.1021/pr0500814 · Cited by 314
Demonstration of cell-bound and humoral immunity against neuroblastoma cells.
Hellström, I. E., Hellström, K. E., Pierce, G. E., & Bill, A. H. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.60.4.1231 · Cited by 306
CEA adhesion molecules: multifunctional proteins with signal-regulatory properties
Öbrink, B. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80114-7 · Cited by 284
Cancer biomarkers: knowing the present and predicting the future
Chatterjee, S. K., & Zetter, B. R. (2005) · Future Oncology · doi:10.1517/14796694.1.1.37 · Cited by 269
A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas
Wu, Y.-J., & Rheinwald, J. G. (1981) · Cell · doi:10.1016/0092-8674(81)90170-7 · Cited by 252
Targeting TGF-β signaling in cancer
Katz, L. H., Li, Y., Chen, J.-S., Muñoz, N. M., Majumdar, A., Chen, J., & Mishra, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.782287 · Cited by 212
Oncofetal reprogramming in tumour development and progression
Sharma, A., Blériot, C., Currenti, J., & Ginhoux, F. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00497-8 · Cited by 94
A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02007-6 · Cited by 29
Nishida (1999) · doi:10.1002/(sici)1096-9098(199907)71:3<140::aid-jso2>3.0.co;2-t
Metadata
- Authors
- Gold, P., & Freedman, S. O.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1965-09-01
- Volume
- 122
- Issue
- 3
- Pages
- 467-481
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2038722446
- Cited by
- 1,879
- References
- 5
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.